COVID-19 changed the world - without changing CTEPH
- PMID: 39209467
- DOI: 10.1183/13993003.01467-2024
COVID-19 changed the world - without changing CTEPH
Conflict of interest statement
Conflicts of interest: I.T. Farmakis has no potential conflicts of interest to disclose. S.V. Konstantinides reports personal lecture/advisory fees and research grants paid to institution from Bayer AG, Boston Scientific, Daiichi-Sankyo, LumiraDx, Penumbra and Inari Medical, and personal lecture/advisory fees from MSD, Pfizer and Bristol Myers Squibb.
Comment on
-
Chronic thromboembolic pulmonary hypertension is an uncommon complication of COVID-19: UK national surveillance and observational screening cohort studies.Eur Respir J. 2024 Aug 29;64(2):2301742. doi: 10.1183/13993003.01742-2023. Print 2024 Aug. Eur Respir J. 2024. PMID: 39060016 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical